Plus Therapeutics, Inc. (PSTV)

Plus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	10	8	11	16	10	9
Market Cap Growth	-24.20%	-25.69%	-33.96%	67.05%	6.69%	136.38%
Enterprise Value	10	4	-2	5	8	3
PE Ratio	-	-0.59	-0.52	-1.20	-1.17	-0.79
PS Ratio	1.63	1.61	47.55	-	31.86	1.29
PB Ratio	-1.60	-5.87	1.65	1.49	3.19	7.80
P/FCF Ratio	-0.66	-0.61	-0.79	-1.56	-1.13	-1.52
P/OCF Ratio	-0.67	-0.62	-0.82	-1.57	-1.14	-1.53
EV/Sales Ratio	1.72	0.72	-8.14	-	27.38	0.47
EV/EBITDA Ratio	-0.77	-0.29	0.10	-0.39	-1.23	-0.41
EV/EBIT Ratio	-0.72	-0.27	0.09	-0.38	-1.16	-0.37
EV/FCF Ratio	-0.71	-0.27	0.14	-0.46	-0.97	-0.55
Debt / Equity Ratio	-0.78	-3.10	0.88	0.65	2.30	10.22
Debt / EBITDA Ratio	-0.35	-0.34	-0.30	-0.58	-1.03	-1.46
Debt / FCF Ratio	-0.32	-0.32	-0.42	-0.67	-0.82	-1.98
Quick Ratio	0.31	0.80	1.53	3.13	0.98	1.30
Current Ratio	0.41	0.92	1.84	3.36	1.07	1.37
Asset Turnover	0.55	0.36	0.01	0	0.02	0.34
Interest Coverage	-38.91	-32.71	-27.52	-13.38	-6.44	-4.87
Return on Equity (ROE)	5226.20%	-805.60%	-192.30%	-113.90%	-364.80%	4164.10%
Return on Assets (ROA)	-105.90%	-97.70%	-87.40%	-62.40%	-56.20%	-55.50%
Return on Capital (ROIC)	1109.04%	-470.21%	-163.04%	-70.07%	-95.68%	-28.10%
Earnings Yield	-118.61%	-168.24%	-190.35%	-83.08%	-85.36%	-126.43%
FCF Yield	-117.62%	-164.38%	-126.56%	-64.25%	-88.32%	-66.00%
Buyback Yield / Dilution	-86.28%	-79.45%	-117.07%	-173.03%	-219.93%	-696.08%
Total Shareholder Return	-86.28%	-79.45%	-117.07%	-173.03%	-219.93%	-696.08%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).